Peptidedrug review Peptide drugs represent a rapidly growing segment of the pharmaceutical industry, offering novel therapeutic solutions for a wide range of conditions. With a significant number of peptide drugs already approved and many more in development, these molecules are solidifying their position as essential therapeutics. The global peptide therapeutics market was valued at approximately $43作者：D Sharma·2025·被引用次数：5—This Review critically states the potential ofpeptidesas versatiletherapeuticsalong with their modifications and advancements to drive the significant ....45 billion in 2023 and is projected for substantial growth, with forecasts indicating a market size exceeding $100 billion by 2030. This expansion is driven by their unique therapeutic potential, the ongoing advancements in drug delivery systems, and the increasing number of peptides currently on the market.
The pharmaceutical market features a robust and expanding presence of peptide drugs. As of recent reports, there are over 80 approved peptide drugs globally, with hundreds more in various stages of clinical development. This substantial pipeline suggests continued innovation and an increasing diversity of peptide-based treatments. The market's trajectory is impressive, with global sales of peptide drugs exceeding $50 billion in 2019 and accounting for a significant portion of the overall pharmaceutical market. Projections indicate continued strong growth, with the market expected to grow at a compound annual growth rate (CAGR) of around 9.作者：AJ Pereira·2024·被引用次数：61—Further, it is estimated the market share of peptide-based drugs will increase to US.7 billion by the year 2030 [1].5% from 2025 to 2035, reaching well over $100 billion.Peptides: Emerging Candidates for the Prevention and Treatment of ... This growth is fueled by breakthroughs in peptide design, improved delivery mechanisms, and the successful application of peptide therapeutics in areas previously difficult to treat.
Peptide drugs are utilized across various therapeutic areas, demonstrating their versatilityPeptide Therapeutics Market - Growth and Forecast to 2035. Notable examples of blockbuster peptide drugs include those targeting metabolic disorders, autoimmune diseases, and cancer. Glucagon-like peptide-1 (GLP-1) analogs, for instance, have seen significant success in managing diabetes and obesity, with drugs like Trulicity, Victoza, and Ozempic leading the market2021年8月5日—In 2019,global sales of peptide drugs exceeded billion, accounting for 5% of the global pharmaceutical market (Figure 2a), with insulin .... Other established peptide therapeutics include Octreotide for acromegaly and certain neuroendocrine tumors, Copaxone for multiple sclerosis, and Teriparatide for osteoporosis. The ongoing research and development efforts are expanding the scope of peptide applications, with emerging candidates focusing on infectious diseases, cardiovascular conditions, and neurological disorders2021年6月18日—The top 8 blockbuster peptide drugs have a combined sales of more than US billion, includingTrulicity, Victoza, Ozempic, Octreotide, Copaxone, Teriparatide....
The therapeutic potential of peptides is being further unlocked through advancements in drug development, particularly in delivery systems. Traditionally, peptides have faced challenges related to poor oral bioavailability and short half-lives, often necessitating parenteral administration. However, innovative approaches, including the development of oral peptide formulations, peptide-drug conjugates, and advanced delivery platforms, are overcoming these hurdlesRecent Advances in Therapeutic Peptides - ACS Publications. These innovations are paving the way for more convenient and effective peptide-based treatments.List of marketed peptide drugs. | Download Table The future of peptide drugs appears bright, with continuous research into novel peptide sequences, modifications, and targeted delivery strategies promising to address unmet medical needs and further expand the market. Companies like Novo Nordisk A/S, Eli Lilly and Company, and Sanofi S.A. are at the forefront of this evolving landscape, driving innovation and bringing new peptide therapeutics to patients.
Join the newsletter to receive news, updates, new products and freebies in your inbox.